Your browser doesn't support javascript.
loading
Survival with Newly Diagnosed Metastatic Prostate Cancer in the "Docetaxel Era": Data from 917 Patients in the Control Arm of the STAMPEDE Trial (MRC PR08, CRUK/06/019).
James, Nicholas David; Spears, Melissa R; Clarke, Noel W; Dearnaley, David P; De Bono, Johann S; Gale, Joanna; Hetherington, John; Hoskin, Peter J; Jones, Robert J; Laing, Robert; Lester, Jason F; McLaren, Duncan; Parker, Christopher C; Parmar, Mahesh K B; Ritchie, Alastair W S; Russell, J Martin; Strebel, Räto T; Thalmann, George N; Mason, Malcolm D; Sydes, Matthew R.
Afiliação
  • James ND; University of Warwick, Coventry, UK. Electronic address: N.D.James@warwick.ac.uk.
  • Spears MR; Medical Research Council Clinical Trials Unit at University College London, London, UK.
  • Clarke NW; Department of Urology, The Christie NHS Foundation Trust, Manchester, UK.
  • Dearnaley DP; Institute of Cancer Research, London, UK; The Royal Marsden NHS Foundation Trust, London and Sutton, UK.
  • De Bono JS; Institute of Cancer Research, London, UK; The Royal Marsden NHS Foundation Trust, London and Sutton, UK.
  • Gale J; Queen Alexandra Hospital, Portsmouth, UK.
  • Hetherington J; Hull & East Yorkshire Hospitals NHS Trust, Hull, UK.
  • Hoskin PJ; Mount Vernon Hospital, Northwood, Middlesex, UK.
  • Jones RJ; University of Glasgow, Beatson West of Scotland Cancer Centre, Glasgow, UK.
  • Laing R; Royal Surrey County Hospital, Guildford, UK.
  • Lester JF; Velindre Hospital, Cardiff, UK.
  • McLaren D; Western General Hospital, Edinburgh, UK.
  • Parker CC; Institute of Cancer Research, London, UK; The Royal Marsden NHS Foundation Trust, London and Sutton, UK.
  • Parmar MKB; Medical Research Council Clinical Trials Unit at University College London, London, UK.
  • Ritchie AWS; Medical Research Council Clinical Trials Unit at University College London, London, UK.
  • Russell JM; Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.
  • Strebel RT; Kantonsspital Graübunden, Chur, Switzerland.
  • Thalmann GN; Department of Urology, University Hospital, Bern, Switzerland.
  • Mason MD; Velindre Hospital, Cardiff, UK.
  • Sydes MR; Medical Research Council Clinical Trials Unit at University College London, London, UK.
Eur Urol ; 67(6): 1028-1038, 2015 Jun.
Article em En | MEDLINE | ID: mdl-25301760
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Taxoides / Antagonistas de Androgênios / Metástase Neoplásica Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Guideline / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Adult / Aged / Aged80 / Humans / Male / Middle aged Idioma: En Revista: Eur Urol Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Taxoides / Antagonistas de Androgênios / Metástase Neoplásica Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Guideline / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Adult / Aged / Aged80 / Humans / Male / Middle aged Idioma: En Revista: Eur Urol Ano de publicação: 2015 Tipo de documento: Article